8-K - Telomir Pharmaceuticals, Inc. (0001971532) (Filer)
Published . Updated .
Filed: 2026-10-06 AccNo: 0001493152-26-045860 Size: 918 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Directly affected
- TELO Telomir Pharmaceuticals
Named in this report.
Indirectly affected
- XPH STATE STREET SPDR S&P PHARMACEUTICALS ETF
GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Filed: 2026-10-06 AccNo: 0001493152-26-045860 Size: 918 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exh…
Source: sec-edgar
Price since this story was published: Telomir Pharmaceuticals (TELO)
Since the first closing price after “8-K - Telomir Pharmaceuticals, Inc. (0001971532) (Filer),” Telomir Pharmaceuticals (TELO) is -7.59%. The S&P 500 fund (SPY) is -1.36% over the same days, a -6.23% difference versus the market.
Who is named in “8-K - Telomir Pharmaceuticals, Inc. (0001971532) (Filer)”
Companies carried with this story
- TELO Telomir Pharmaceuticals
For “8-K - Telomir Pharmaceuticals, Inc. (0001971532) (Filer),” Telomir Pharmaceuticals (TELO) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> TELO
- XPH State Street Spdr S&P Pharmaceuticals Etf
State Street Spdr S&P Pharmaceuticals Etf (XPH) is linked, with no stored direction, medium confidence in the 6 Oct 2026 story “8-K - Telomir Pharmaceuticals, Inc. (0001971532) (Filer).” Reason on file: GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “8-K - Telomir Pharmaceuticals, Inc. (0001971532) (Filer)” reaches Telomir Pharmaceuticals (TELO)
The 6 Oct 2026 story “8-K - Telomir Pharmaceuticals, Inc. (0001971532) (Filer)” names Telomir Pharmaceuticals (TELO) because of this story.
What ties Telomir Pharmaceuticals (TELO) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> TELO
Also listed, State Street Spdr S&P Pharmaceuticals Etf (XPH): GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Dates in the story, and the Telomir Pharmaceuticals (TELO) price range
TELO traded between 1.03 and 1.58 across 8 sessions. The latest close on file is 1.03. XPH traded between 61.54 and 68.95 across 20 sessions. The latest close on file is 62.24.
What the saved facts support for Telomir Pharmaceuticals (TELO)
21 out of 100
“8-K - Telomir Pharmaceuticals, Inc. (0001971532) (Filer)” scores 21 out of 100. The score uses 1 sources, and 2 linked companies.